Making best practice, everyday practice

Login Register

Diabetes: ACTing on evidence

Acting on the evidence


An educational programme for General Practice developed by international experts – Dr Lawrence Leiter and Dr Subodh Verma (Canada)


Participation in this fully accredited CPD programme gives you the opportunity to learn how:

  • To interpret latest data on cardiovascular protection
  • Differentiate cardiovascular outcome trial results practically to identify at-risk patients in your practice
  • The benefits and risks of SGLT-2 inhibitor therapy
  • To understand the renal benefits of SGLT-2 inhibitors and apply this therapy in your practice



Dr Lawrence A Leiter

Division of Endocrinology and Metabolism
St Michael’s Hospital
Professor of Medicine and Nutritional Sciences,
University of Toronto, Toronto, ON, Canada.
Dr Subodh Verma

Division of Cardiac Surgery
St Michael’s Hospital
Professor of Surgery and Pharmacology & Toxicology
University of Toronto, Toronto, ON, Canada
Canada Research Chair in Cardiovascular Surgery

EARN 15 CPD points by completing this programme

ACT 1: Cardiovascular and renal protection in diabetes »
ACT 2: Cardiovascular outcome trials in diabetes »
ACT 3: Renal protection in diabetes »
ACT 4: Review of renal therapies prior to SGLT-2 inhibitor therapy »
ACT 5: Renal benefits of SGLT-2 inhibitors in diabetes »
ACT 6: SGLT-2 inhibitors and safety »

Each module provides knowledge and expert comment

Supported by an unrestricted grant

Do you like this? If you want to share it: